A carregar...
A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014–2019)
INTRODUCTION: Histone deacetylase 6 (HDAC6) is unique in comparison with other zinc-dependent HDAC family members. An increasing amount of evidence from clinical and preclinical research demonstrates the potential of HDAC6 inhibition as an effective therapeutic approach for the treatment of cancer,...
Na minha lista:
| Publicado no: | Expert Opin Ther Pat |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6950832/ https://ncbi.nlm.nih.gov/pubmed/31865813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543776.2019.1708901 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|